Establishment Labs Holdings Inc. (ESTA)
NASDAQ: ESTA · Real-Time Price · USD
45.40
-0.84 (-1.82%)
Dec 27, 2024, 11:29 AM EST - Market open
Company Description
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery.
The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.
The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia.
Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Establishment Labs Holdings Inc.
Country | Costa Rica |
Founded | 2004 |
IPO Date | Jul 19, 2018 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 908 |
CEO | Juan Chacon Quiros |
Contact Details
Address: Building B15 and 25, Coyol Free Zone Alajuela Costa Rica | |
Phone | 506 2434 2400 |
Website | establishmentlabs.com |
Stock Details
Ticker Symbol | ESTA |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001688757 |
CUSIP Number | G31249108 |
ISIN Number | VGG312491084 |
Employer ID | 98-1436377 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Juan Jose Chacon Quiros | Founder, Chief Executive Officer and Executive Director |
Rajbir Singh Denhoy | Chief Financial Officer |
S. Ross Mansbach | General Counsel, Chief Compliance Officer and Chief Human Resources Officer |
Filippo Caldini | President |
Roberto de Mezerville | Chief Technology Officer |
Salvador Santos Dada | Head of Special Projects |
Rosalyn Cole d'Incelli | SVice President of Global Clinical, Medical and US Regulatory Affairs |
Ivan Bilic | Senior Vice President of Commercial Operations - OUS |
Jeff Ehrhardt | Senior Vice President and GM of North America |
Neeta Toprani | Corporate Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 14, 2024 | SCHEDULE 13G/A | Filing |
Nov 12, 2024 | 10-Q | Quarterly Report |
Nov 12, 2024 | 8-K | Current Report |
Nov 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Nov 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
Nov 8, 2024 | 424B5 | Filing |
Nov 7, 2024 | 8-K | Current Report |
Nov 7, 2024 | 8-K | Current Report |
Sep 26, 2024 | 8-K | Current Report |
Aug 26, 2024 | 8-K | Current Report |